as on March 3, 2026 at 7:59 am IST
Day's Low
Day's High
4.52%
Downside
3.90%
Upside
52 Week's Low
52 Week's High
57.87%
Downside
4.39%
Upside
Check Moderna, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$20.9B
EPS (TTM)
-6.6754
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.85%
PE Ratio (TTM)
-5.08
Industry PE ratio
17.3774358974359
PEG Ratio
0EBITDA
-2.9B
Revenue (TTM)
1.9B
Profit Margin
-145.16%
Return On Equity TTM
-28.87%
Track how Moderna, Inc. P/E has moved over time to understand its valuation trends.
Moderna, Inc. in the last 5 years
Lowest (-15.78x)
September 30, 2024
Today (-5.08x)
March 3, 2026
Industry (17.38x)
March 3, 2026
Highest (115.93x)
March 31, 2021
Today’s Price to Earnings Ratio: -5.08x
Compare market cap, revenue, PE, and other key metrics of Moderna, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $20.9B | -59.73% | -5.08 | -145.16% | |
| BUY | $44.2B | 125.24% | 142.88 | 8.45% | |
| BUY | $126.2B | 133.18% | 32.47 | 32.94% | |
| NA | $35.1B | NA | 621.55 | 5.37% | |
| BUY | $82.6B | 77.02% | 18.83 | 31.41% |
The Moderna, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Moderna, Inc. investment value today
Current value as on today
₹1,79,512
Returns
₹79,512
(+79.51%)
Returns from Moderna, Inc. Stock
₹74,694 (+74.69%)
Dollar Returns*
₹4,817 (+4.82%)
Based on 31 analysts
54.84%
Buy
35.48%
Hold
9.68%
Sell
Based on 31 analysts, 54.84% of analysts recommend a 'BUY' rating for Moderna, Inc.. Average target price of $42.25
Get share price movements and forecasts by analysts on Moderna, Inc..
What analysts predicted
-25.16%DOWNSIDE
Target Price
$42.25
Current Price
$52.88
Analyzed by
31 Analysts
Target
$42.25
Moderna, Inc. target price $42.25, a slight downside of -25.16% compared to current price of $52.88. According to 31 analysts rating.
Investment in Moderna, Inc. Shares on INDmoney has dropped by -52.73% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Moderna, Inc. Stock has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 19 February
Thu, 09:00 PM
-Moderna announces FDA will review its mRNA flu vaccine application, reversing previous rejection, boosting investor confidence.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
![]()
In the last 1 year, MRNA has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 1 month, MRNA stock has moved up by 25.2%
Against Peers
![]()
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 60.5% return, outperforming this stock by 123.6%
Profit Down
![]()
Netprofit is down for the last 2 quarters, -200.0M → -826.0M (in $), with an average decrease of 313.0% per quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 1.01B → 678.0M (in $), with an average decrease of 33.3% per quarter
| Organisation | Moderna, Inc. |
| Headquarters | 325 Binney Street, Cambridge, MA, United States, 02142 |
| Industry | Health Technology |
| CEO | Mr. Stéphane Bancel M.B.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Lavina Talukdar CFA | Senior VP & Head of Investor Relations |
Ms. Tracey Franklin | Chief People & Digital Technology Officer |
Dr. Charbel Haber M.P.H., Ph.D. | Senior VP & Head of Global Regulatory Science |
Dr. Stephen Hoge M.D. | President |
Mr. James M. Mock | Chief Financial Officer |
Ms. Shannon Thyme Klinger J.D. | Chief Legal Officer & Corporate Secretary |
Dr. Jerh Collins Ph.D. | Chief Technical Operations & Quality Officer |
Dr. Melanie Ivarsson M.B.A., O.B.E., Ph.D. | Chief Development Officer |
Mr. Dave Johnson | Chief Data & AI Officer |
Mr. Stéphane Bancel M.B.A. | CEO & Director |
Moderna, Inc. share price today is $52.88 as on at the close of the market. Moderna, Inc. share today touched a day high of $54.94 and a low of $50.49.
Moderna, Inc. share touched a 52 week high of $55.2 on and a 52 week low of $22.28 on . Moderna, Inc. stock price today i.e. is closed at $52.88,which is 4.20% down from its 52 week high and 137.34% up from its 52 week low.
Moderna, Inc. market capitalisation is $0.02T as on .
Indian investors can start investing in Moderna, Inc. (MRNA) shares with as little as ₹91.474 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹914.74 in Moderna, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Moderna, Inc. share’s latest price of $52.88 as on March 3, 2026 at 2:29 am IST, you will get 0.1891 shares of Moderna, Inc.. Learn more about
fractional shares .
Moderna, Inc. stock has given -59.73% share price returns and 24.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?